Amgen Reportedly to Pay $74 Million to Settle Shareholder Suit Over Delayed IRS Tax Disclosure

MT Newswires Live07-22

Amgen (AMGN) agreed to pay $74 million to settle a shareholder lawsuit alleging the company waited too long to disclose it may owe the Internal Revenue Service $10.7 billion in back taxes, penalties and interest, news outlets reported Tuesday.

The preliminary settlement, filed Monday in federal court in Manhattan, requires court approval, Reuters reported. Shareholders alleged Amgen's delayed disclosures caused its stock price to fall on dates in August 2021 and April 2022.

Amgen continues to view the claims as meritless, and the settlement does not amount to an admission of liability or wrongdoing, Fierce Pharma reported, citing a company spokesperson.

Amgen didn't immediately respond to a request for comment from MT Newswires.

Price: 370.10, Change: +3.86, Percent Change: +1.05

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment